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Anti-diabetic activity of Tinospora cordifolia (Willd.) in
streptozotocin diabetic rats; does it act like sulfonylureas?
Nagaraja PURANIK1, Kararashah Fakruddin KAMMAR2, Sheela DEVI1

Aim: As an alternative medicine to treat diabetes mellitus, many herbal drugs are being studied throughout the world.
In the present study, an attempt was made to investigate the anti-diabetic activity of Tinospora cordifolia (Willd.) (TC)
stem extracts (both aqueous and alcoholic) in different dosages (200 and 400 mg/kg b.w.) in streptozotocin diabetic
albino rats. The probable mechanism by which TC may act as an anti-hyperglycemic drug was also investigated.
Materials and methods: The drug was administered orally for 10 days and 30 days in different groups of animal, with
each group containing 6 animals. The efficacy of this drug was compared with the Lante Zinc Insulin (6 U/kg b.w. daily,
i.p.) treated diabetic rats. The serum insulin levels, histology of endocrine pancreas and activity of key enzymes of glucose
metabolism, i.e. glycogen synthase and glycogen phosphorylase, were studied.
Results: Our study clearly showed that TC has significant (P < 0.05) anti-diabetic activity in diabetic animals and has an
efficacy of 40% to 80% compared to insulin. TC administration in diabetic animals did not cause any increase in serum
insulin levels or regeneration of pancreatic β cells but caused increased hepatic glycogen synthase and decreased glycogen
phosphorylase activity.
Conclusion: The probable mechanism by which TC may act as an anti-hyperglycemic drug is not through insulin
secretion like sulfonylureas. It may be through some peripheral mechanisms, such as increasing the glycogen storage in
the liver or decreasing the glucose release from the liver.
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Introduction
Diabetes mellitus (DM) is a metabolic disorder that affects people of all age groups and from all
walks of life. There are an estimated 150 million people worldwide suffering from diabetes (1),
which is almost 5 times more than the estimated number 10 years ago.
Management of diabetes without any side effects is still a challenge in the medical field, as
presently available drugs for diabetes have one or more adverse effects (2). Since the existing drugs
for the treatment of DM do not satisfy our need completely, the search for new drugs continues. In
recent years, herbal remedies for the unsolved medical problems have been gaining importance in
the research field. Although many researchers have studied the anti-diabetic activity of Tinospora
cordifolia, no satisfactory study was conducted to investigate its efficacy in streptozotocin induced
diabetic rats or to explore how this drug acts as an anti-diabetic agent. Thus, this study was
undertaken to explore the efficacy of anti-diabetic activity of Tinospora cordifolia in diabetic rats.
The possible mechanism by which this drug may act is discussed in this study.
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Tinospora cordifolia (Willd.) Miers ex Hook. F. &
Thoms. (TC) belongs to the family Menispermaceae
and is known as Gulancha in English, Guduchi in
Sanskrit, and Giloya in Hindi. It is a large, glabrous,
deciduous climbing succulent shrub, commonly
found in hedges. It has been known for long in the
Ayurvedic literature (i.e. the system of traditional
medicine native to India and practiced in other parts
of the world as a form of alternative medicine) as a
tonic and vitalizer and as a remedy for diabetes and
other metabolic disorders (3,4).
Materials and methods
Plant material and extraction
Tinospora cordifolia stem was collected fresh from
the forest areas in Udupi- district, Karnataka state,
South India, and dried in the shade and then
powdered. The plant was identified by Professor and
Head of the Department of Botany, Mangala
Gangothri, Mangalore University. A specimen
(Voucher No. 31) was deposited in the botany
department museum. The powdered materials were
kept in an air-tight container in a refrigerator until the
time of use.
Aqueous and alcoholic extracts of TC were
prepared according to the standard extract procedure
(5). The yield of extracts was approximately 8.5% and
7%, respectively.
Animals
Female albino rats of inbred Wistar strain (body
wt. 180-210 g) were used in this study. Animal ethical
committee clearance was obtained from Institutional
Animal Ethics Committee (IACE No. 08/004/02). The
animals were fed on a pellet diet (Hindustan Lever
Ltd. Bangalore) and water ad libitum throughout the
study period. All the experiments were carried out in
between 8 and 10 A.M in order to avoid circadian
rhythm induced changes.
Experimental groups
All the experimental animals were divided into 7
groups with each group consisting of 6 animals as
follows:
Group 1- Control: This group was used for
studying the baseline values of the parameters studied.
Group 2- Diabetic control: This group consisted of
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streptozotocin induced diabetic rats. Group 3Diabetic rats treated with (200 mg/kg b.w.) aqueous
extract of TC. Group 4- Diabetic rats treated with
(400 mg/kg b.w.) aqueous extract of TC. Group 5Diabetic rats treated with (200 mg/kg. b.w) alcoholic
extract of TC. Group 6- Diabetic rats treated with
(400 mg/kg. b.w.) alcoholic extract of TC. Group 7Diabetic rats treated with insulin.
Experimental induction of diabetes
To induce diabetes, the rats were fasted for 16 h
and injected with freshly prepared streptozotocin
(STZ) (Sigma Chemicals, USA) at the dose of 55
mg/kg b.w. intravenously (6) in 0.1 M citrate buffer of
pH 4.5 (7). Control animals received citrate buffer
alone.
Diabetes status was confirmed by estimating the
fasting blood glucose levels and urine glucose
(Benedict’s test) after 72 h of STZ injection. Animals
showing fasting blood glucose levels above 250 mg/dL
were selected for this study.
Drug treatment
Single dosage of either aqueous extract (dissolved
in normal saline) or alcoholic extract (dissolved in
gum acacia) (5) was given orally for 10 days and 30
days to specific groups through oral intubations and
the control animals received the vehicle with TC.
Lante zinc insulin (6 units/kg. b.w. i.p) was given to
the specific group daily (8).
Biochemical and histological studies
At the end of the experimental period, the animals
were killed by cervical decapitation. Fasting blood
samples and serum were collected. Serum was also
collected 1 h after giving the drug in the specific
group. The liver was removed and kept in a deep
freeze (–20 °C) and later used for the estimation of
enzymes. The pancreas was removed and was fixed in
10% buffered formalin for the histological studies.
Fasting blood glucose was estimated by the glucose
oxidase method described by Trinder (9). Glycogen
synthase (EC 3.1.3.42) and glycogen phosphorylase
(EC 2.4.1.1) activities in the liver were estimated as
described by Leloir and Goldenberg (10) and
Cornblath et al. (11), respectively. Histology studies
of pancreas were carried out according to the
procedure reported by Culling (12). Serum insulin
levels were assayed using a standard Mercodia Rat
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Insulin ELISA enzyme immunoassay kit from
Mercodia, Sweden (cat. no-10-1124-01).
Statistical analysis
Statistical significance between the different
groups was determined using one way analysis of
variance (ANOVA) followed by Tukey’s multiple
comparisons by fixing the P value as <0.05.
Results and discussion
The present study clearly showed that TC has
significant (P < 0.05) anti-diabetic activity in diabetic
animals and has an efficacy of 40% to 80% compared
to insulin. TC administration in diabetic animals did
not show any increase in serum insulin levels or
regeneration of pancreatic β cells but showed
increased hepatic glycogen synthase and decreased
glycogen phosphorylase activity.
Fasting hyperglycemia is a hallmark of DM. It has
been postulated but is still debated that the fasting
hyperglycemia in non-insulin dependent DM arises
from the hepatic overproduction of glucose (13).
However, studies by Jae et al. (14) suggest that the
post-absorptive hyperglycemia in STZ diabetic rats is
largely due to decreased peripheral glucose clearance,
while increased hepatic glucose output might also be
a contributing factor at a very high STZ dose. In the
present study, the streptozotocin induced diabetic
animals showed elevated fasting blood glucose levels
(Table 1). Insulin treatment in these diabetic rats
could not return the blood glucose to normal levels
during the study period although blood glucose was

decreased notably. The reason for this observation
may be that the insulin was injected almost 24 h
before the blood sample was taken and during this gap
period the insulin injected (single dose) might have
been inactivated or the dosage used might have been
insufficient. Treatment with TC in diabetic rats could
significantly reduce the fasting blood glucose levels
after 10 and 30 days of treatment. However, blood
glucose in these treated groups was at elevated levels
compared to insulin treated diabetic rats and controls.
The efficacy of this anti-diabetic activity of TC was
fairly good compared to insulin.
The importance of the liver in the regulation of
carbohydrate metabolism is recognized by its ability
to store carbohydrates in the form of glycogen
(glycogenesis) and to release them in the form of
glucose (glycogenolysis) when needed. These
processes are regulated by 2 key enzymes: glycogen
synthase and glycogen phosphorylase. It is reported
that in diabetic animals the glycogen synthase activity
was decreased whereas phosphorylase activity
increased (15). In the present study, the liver glycogen
synthase activity decreased and phosphorylase
activity increased substantially (Table 2) in untreated
diabetic rats during the study period. The treatment
with TC as well as insulin showed effects on the
glycogen synthase and phosphorylase activity in these
animals. These increased glycogen synthase activities
in the liver of TC treated diabetic animals may
indicate that the TC decreases blood sugar by
increasing the glycogen storage in the liver. It seems
that, since the TC treatment could not normalize the

Table 1. Effect of TC extracts on fasting blood glucose and comparison of efficacy of TC extracts with insulin (values expressed in %
amelioration towards normal levels).

Fasting blood

Days

Control

Diabetic
control

11th day

89.17 ± 5.1*

353.24 ± 4.5*a
a

st

Diabetic
+Aq.200

Diabetic
+Aq.400

162.68 ± 12.7*a
a

Diabetic
+Al. 200

Diabetic
+Al. 400

Diabetic
+Insulin

221.74 ± 5.2*a

196.45 ± 5.6*a

215.57 ± 4.4*

126.21 ± 2.8

a

236.87 ± 3.0*

228.90 ± 2.9*a

214.27 ± 2.9*

138.20 ± 2.1

glucose (mg/ dL)

31 day

89.60 ± 2.5*

346.97 ± 5.5*

190.69 ± 6.5*

Efficacy (%)

11th day

-

-

72.16

49.79

59.37

52.13

85.97

-

-

60.72

42.77

45.87

51.56

81.11

st

31 day

Data expressed as mean ± SD (n = 6) P < 0. 05
* Control vs. other groups
a
Diabetic control vs. TC treated diabetic groups.
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TC treated diabetic rats (Figure) did not reveal any
evidence of regeneration of beta cells of islets of
Langerhans. The histology section of the pancreas of
the drug treated control rats showed the normal
architecture of the islets of Langerhans with the
granulated beta cells appearing dark. The histology of
the pancreas in diabetic rats showed small and
shrunken islets of Langerhans. Destruction of beta
cells was observed in this section. The histology of the
pancreas in TC treated diabetic rats showed a similar
architecture to that of diabetic rats. There was no
considerable change in the architecture of the islets of
Langerhans after the TC treatment. It appears that

phosphorylase activity in the liver, the blood glucose
was at elevated levels in TC treated diabetic rats in
spite of the enhanced glycogen synthase activity.
STZ is well known for its selective beta cell
cytotoxicity. It is reported that in STZ induced
diabetic rats the beta cell count/islet and the serum
insulin levels decrease considerably (7). In the present
study, the serum insulin levels also decreased
drastically in untreated diabetic rats. Treatment with
TC by administration of a single dosage of extract or
for 10 and 30 days (Table 3) did not increase the
serum insulin levels in diabetic animals. In addition,
the histological examination of endocrine pancreas in

Table 2. Effect of TC extracts on hepatic glycogen phosphorylase, glycogen synthase activities, and comparison of efficacy of TC extracts
with insulin (values expressed in % amelioration towards normal levels).

Glycogen synthase
activity (μmol of

Days

Control
control

Diabetic
+Aq.200

th
11 day

659.88 ± 6.08*

918.65 ± 4.08*a

735.82 ± 5.53*a

660.12 ± 3.99*

a

a

st

Diabetic
+Aq.400

Diabetic
+Al. 200

Diabetic
+Al. 400

Diabetic
+Insulin

Diabetic

742.35 ± 4.89*a

741.78 ± 2.76*a

744.15 ± 3.71*

694.12 ± 2.86

a

742.90 ± 3.68*a

739.67 ± 3.36*

701.87 ± 2.46

UDP formed/mg
protein/h).

31 day

Efficacy (%)

11th day

-

-

70.65

68.12

68.35

67.43

86.77

st
31 day

-

-

71.97

70.01

66.87

68.17

83.29

Glycogen synthase
activity (μmol of

910.05 ± 4.16*

730.15 ± 3.05*

735.07 ± 3.19*

th
11 day

179.85 ± 4.9*

48.98 ± 3.7*a

93.93 ± 2.1*a

80.41 ± 2.4*a

90.43 ± 2.4*a

83.33 ± 1.8

177.03 ± 6.4

UDP formed/mg
protein/h).

31st day

177.08 ± 4.00*

54.56 ± 2.5*a

94.11 ± 2.7*a

80.56 ± 4.6*a

91.20 ± 3.9*a

87.40 ± 2.1

179.87 ± 4.2

Efficacy (%)

11 day

th

-

-

34.34

24.01

31.67

26.24

97.85

st

-

-

32.28

21.22

29.90

26.80

98.77

31 day

Data expressed as mean ± SD (n = 6) P < 0. 05
* Control vs. other groups
a
Diabetic control vs. TC treated diabetic groups.

Table 3. Effect of TC extract on serum insulin levels (pmol/L).

Fasting
1 h after giving TC

Control

Diabetic
control

Diabetic
+Aq.200

Diabetic
+Aq.400

Diabetic
+Al. 200

Diabetic
+Al. 400

473.11 ± 12.6

135.98 ± 13.08*

49.63 ± 10.20

147.5 ± 12.38

151.95 ± 6.68*

150.48 ± 10.68

470.56 ± 16.78*

142.83 ± 6.7*

145.16 ± 12.9*

150 ± 15.6*

146.16 ± 8.8*

148.33 ± 12.7

th

473.32 ± 13.2*

135.98 ± 10.40*

149.63 ± 8.66*

147.50 ± 10.70*

151.95 ± 12.91*

150.48 ± 7.00

st

460.08 ± 9.66*

147.50 ± 7.89*

160.74 ± 8.08*

163.83 ± 12.81*

160.89 ± 12.02*

159.65 ± 9.54

On 11 day
On 31 day

Data expressed as mean ± SD (n = 6) P < 0. 05
* Control vs. other groups
a
Diabetic control vs. TC treated diabetic groups.
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10X
Non-diabetic control animal treated with 400 mg/kg b.w. of TC extract.

45X

10X
Untreated diabetic control.

45X

10X
Diabetic animal treated with TC

45X

Figure. Effect of TC on endocrine pancreas.

there was no regeneration of beta cells after the TC
treatment; therefore, it appears that the antihyperglycemic activity of TC is not through the
insulin secretion and is independent of insulin
secretion by pancreatic beta cells. Moreover, in the
present study, treatment with 400 mg of extracts of TC
in control rats for 30 days did not show any adverse
effects on the normal histology of the pancreas. Since
the present study has some limitations by having
limited experimental sample size and methodology,
this observation may be suggestive of a need for
further research in the future to examine the adverse
effects of this drug.

Conclusion
Tinospora cordifolia is an effective antihyperglycemic drug that can be used in the treatment
of DM. Although its activity is feeble compared to
insulin, it can be used as a supportive drug in the
treatment of DM. The anti-diabetic activity of TC is
not through the insulin secretion by pancreatic beta
cells. It may be due to the increased entry of glucose
into the peripheral tissues and organs like the liver.
Since TC increased the activity of glycogen synthase
in the liver, it may increase the storage of glucose in
hepatocytes. It also decreased the activity of
phosphorylase in the liver; thereby it may prevent the
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release of glucose into the blood. These observations
strongly suggest that TC may not act like
sulfonylureas, but like other oral anti-hyperglycemic

drugs. This study indicates that treatment with TC
may be an alternative to some of the presently
available drugs, which have some adverse effects.
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